Alimera Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ALIM and buy or sell other stocks, ETFs, and their options commission-free!

About ALIM

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the following geographical segments: U.S. and International. 

CEO
Richard S. Eiswirth, Jr., CPA
CEORichard S. Eiswirth, Jr., CPA
Employees
Employees
Headquarters
Alpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded
2003
Founded2003
Employees
Employees

ALIM Key Statistics

Market cap
290.23M
Market cap290.23M
Price-Earnings ratio
-18.13
Price-Earnings ratio-18.13
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$5.65
52 Week high$5.65
52 Week low
$2.77
52 Week low$2.77

Stock Snapshot

The current Alimera Sciences(ALIM) stock price is $8.99, with a market capitalization of 290.23M. The stock trades at a price-to-earnings (P/E) ratio of -18.13.

On 2026-03-09, Alimera Sciences(ALIM) stock opened at —, reached a high of —, and a low of —.

The Alimera Sciences(ALIM)'s current trading volume is 0.

In the last year, Alimera Sciences(ALIM) shares hit a 52-week high of $5.65 and a 52-week low of $2.77.

In the last year, Alimera Sciences(ALIM) shares hit a 52-week high of $5.65 and a 52-week low of $2.77.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.